Bile salt-induced cytotoxicity and ursodeoxycholate cytoprotection: In-vitro study in perifused rat hepatocytes

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 7, 1997, Pages 703-709

  Pazzi, Paolo ^a   Puviani, Anna C ^b   Libera, Mauro Dalla ^a   Guerra, Giovanni ^a   Ricci, Daniele ^b   Gullini, Sergio ^a   Ottolenghi, Celestina ^b  

^a S ANNA HOSPITAL   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Bile acids; Hepatocytoprotection; Hepatotoxicity; Isolated hepatocytes; Perifused hepatocytes; Ursodeoxycholic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILE SALT; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID; LACTATE DEHYDROGENASE; LIVER ENZYME; RESIN; TRITON X 100; URSODEOXYCHOLIC ACID;

ANIMAL CELL; ARTICLE; CHRONIC LIVER DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME RELEASE; HYDROPHILICITY; HYDROPHOBICITY; LIVER CELL; LIVER DISEASE; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TIME;

EID: 0030746085     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199707000-00011     Document Type: Article

References (48)

1. Miyai K , Price VM, Fisher MM: Bile acid metabolism in mammals. Ultrastructural studies on the intrahepatic cholestasis induced by lithocholic and chenodeoxycholic acids in the rat. Lab Invest 1971, 24:292-302.
2. Drew R, Priestly BG: Choleretic and cholestatic effects of infused bile salts in the rat. Experientia 1978, 35:809-811.
3. Schmucker DL, Ohta M, Kanai S, et al.: Hepatitis injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 1990, 12:1216-1221.
4. Miyazaki K, Nakayama F, Koga A: Effects of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes. Dig Dis Sci 1984, 29:1123-1130.
5. Yousef IM, Bloxman DL, Phillips MJ, et al.: Liver cell plasma membrane lipids and the origin of biliary phospholipids. Can J Biochem 1975, 53:989-997.
6. Scholmerich J, Becher MS, Schmidt K, et al.: Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties. Studies on isolated hepatocytes and lipid membrane vesicles. Hepatology 1984, 4:661-666.
7. Ohta M, Kanai S, Kitani K: The order of hepatic cytotoxicity of bile salts in vitro does not agree with that examined in vivo in rats. Life Sci 1990, 46:1503-1508.
8. Guldutuna S, Zimmer C, Imhof M, et al.: Molecular aspects of membrane stabilization by ursodeoxycholate. Gastroenterology 1993, 104:1736-1744.
9. DeRubertis FR, Craven PA: Relationship of bile salt stimulation of colonic epithelial phospholipid turnover and proliferative activity: role of activation of protein kinase C. Prev Med 1987, 16:572-579.
10. Krahenbuhl S, Talos C, Fischer S, et al.: Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria. Hepatology 1994, 19:471-479.
11. Poupon RE, Balkau B, Eschwege E, et al.: A multicenter controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991, 324:1548-1554.
12. Leuschner U, Fisher H, Kurtz W, et al.: Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology 1989, 97:1268-1274.
13. Beuers U, Spengler U, Kruis W, et al.: Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 1992, 16:707-714.
14. Kitani K, Ohta M, Kanai S: Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat. Am J Physiol 1985, 248:G407-G417.
15. Galle PR, Thielmann L, Raedsch R, et al.: Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology 1990, 12:486-491.
16. Schoelmerich J, Baumgartner U, Miyai K, et al.: Tauroursodeoxycholate prevents taurolithocholate-induced cholestasis and toxicity in rat liver. J Hepatol 1990, 10:280-283.
17. Heuman DM, Mills SA, McCall J, et al.: Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. Gastroenterology 1991, 100:203-211.
18. Heuman DM, Pandak WM, Hylemon PB, et al.: Conjugates of ursodeoxycholate protect against toxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes. Hepatology 1991, 14:920-926.
19. Batta AK, Salen G, Arora R, et al.: Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. Hepatology 1989, 10:414-419.
20. Crosignani A, Podda M, Battezzati PM, et al.: Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. Hepatology 1991, 14:1000-1007.
21. Kitani K, Kanai S: Tauroursodeoxycholate prevents taurocholate-induced cholestasis. Life Sci 1982, 30:515-523.
22. Lim AG, Ahmed HA, Jazrawi RP, et al.: Effects of bile acids on human hepatic mitochondria. Eur J Gastroenterol Hepatol 1994, 6:1157-1163.
23. Krahenbuhl S, Fischer S, Talos C, et al.: Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria. Hepatology 1994, 20:1595-1601.
24. Botla R, Spivey JR, Aguilar H, et al.: Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. J Pharmacol Exp Ther 1995, 272:930-938.
25. Ota S, Tsukahara H, Terano A, et al.: Protective effect of tauroursodeoxycholate against chenodeoxycholate-induced damage to cultured rabbit gastric cells. Dig Dis Sci 1991, 30:409-416.
26. Ottolenghi C, Puviani AC, Fabbri E, et al.: Hormone responsiveness of isolated catfish hepatocytes in perifusion system is higher than in flasks incubation. Gen Comp Endocrinol 1994, 95:52-59.
27. Mine T, Kojima I, Ogata E: Difference in sensitivity to glucagon action in three different rat liver systems. Metab Clin Exp 1990, 39:321-326.
28. Seglen PO: Preparation of isolated rat liver cells. In Methods in Cell Biology, Vol XIII, Ch 4. Edited by Prescott DM. New York: Academic Press; 1976:29-80.
29. Igimi H, Carey MC: pH-solubility relations of chenodeoxycholic and ursodeoxycholic acids: physical-chemical basis for dissimilar solution and membrane phenomena. J Lipid Res 1980, 21:72-89.
30. Hofmann AF, Roda A: Physicochemical properties of bile acids and their relationship to biological properties: an overview of the problem. J Lipid Res 1984, 25:1477-1479.
31. Attili AF, Angelico M, Catanfora A, et al.: Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. Med Hypotheses 1986, 19:57-69.
32. Armstrong MJ, Carey MC: The hydrophobic-hydrophilic balance of bile salts. Inverse correlation between reverse-phase high performance liquid chromatographic mobilities and micellar cholesterol-solubilizing capacities. J Lipid Res 1982, 23:70-80.
33. Phillips JM, Fisher RL, Anderson DW, et al.: Ultrastructural evidence of intrahepatic cholestasis before and after chenodeoxycholic acid therapy in patients with cholelithiasis: the National Cooperative Gallstone Study. Hepatology 1983, 3:209-220.
34. Schenfield LJ, Lachin JM, and the Steering Committee for the National Cooperative Gallstone Study Group: Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the national cooperative study: a controlled trial of efficacy and safety. Ann Intern Med 1981, 95:257-282.
35. LaRusso NF, Szczepanik PA, Hofmann AF: Effect of deoxycholic acid ingestion on bile acid metabolism and biliary lipid secretion in normal subjects. Gastroenterology 1977, 72:132-140.
36. Zhao XM, Montet JC: Effects of bile salt supplementation on biliary secretion in estrogen-treated rats. J Nutr Biochem 1990, 1:420-425.
37. Queneau PE, Bertault-peràs P, Mesdjian E, et al.: Diminution of an acute cyclosporine A-induced cholestasis by tauroursodeoxycholate in the rat. Transplantation 1993, 56:530-534.
38. Krol T, Kitamura T, Miyai K, et al.: Tauroursodeoxycholate reduces ductular proliferation and portal inflammation in bile-duct ligated hamsters. Hepatology 1983, 3:335A.
39. Poo JL, Feldmann G, Erlinger S, et al.: Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat. Gastroenterology 1992, 102:1752-1759.
40. Yousef IM, Barnwell S, Gratton F, et al.: Liver cell membrane stabilization may control maximum secretory rate of cholic acid in the rat. Am J Physiol 1987, 252:G84-G91.
41. Barnwell SG, Lowe PJ, Coleman R: Effect of taurochenodeoxycholate upon biliary output of phospholipids and plasma-membrane enzymes, and the extent of cell damage, in isolated perfused rat livers. Biochem J 1983, 216:107-111.
42. Okishio T, Nair PP: Studies of bile acids. Some observations on the intracellular localization of major bile acids in rat liver. Biochemistry 1966, 5:3662-3668.
43. Cronholm T, Sjovall J: Bile acids in portal blood of rats fed different diets and cholestyramine. Bile acids and steroids. Eur J Biochem 1967, 2:375-383.
44. Bremmelgaard A, Alme B: Analysis of plasma bile acid profiles in patients with liver diseases associated with cholestasis. Scand J Gastroenterol 1980, 15:593-600.
45. Greim H, Czygan P, Schaffner F, et al.: Determination of bile acids in needle biopsies of human liver. Biochem Med 1973, 8:280-286.
46. Spivey JR, Bronk SF, Gores GJ: Glycochenodeoxycholate induced lethal hepatocellular injury in rat hepatocytes. J Clin Invest 1993, 92:17-24.
47. Cowen AE, Korman AG, Hofmann AF, et al.: Plasma disappearance of radioactivity after intravenous injection of labeled bile acids in man. Gastroenterology 1975, 68:1567-1573.
48. Chitranukroh A, Billing BH: Changes in the binding of radioactive conjugated bile salts to serum proteins in cholestatic jaundice. Cin Sci 1983, 65:661-666.